Graham Capital Management, L.P. Bridge Bio Pharma, Inc. Transaction History
Graham Capital Management, L.P.
- $5.08 Billion
- Q4 2024
A detailed history of Graham Capital Management, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 4,725 shares of BBIO stock, worth $180,589. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,725
Previous 32,421
85.43%
Holding current value
$180,589
Previous $825,000
84.36%
% of portfolio
0.0%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
324Shares Held
178MCall Options Held
12.8MPut Options Held
2.51M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$965 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$960 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$576 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$476 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$236 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.67B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...